Effect of switching branded risedronate to branded or generic alendronate on medication compliance with weekly bisphosphonates: a cohort study utilizing the dapi prescription claims database

Schüssel K Czeche S Möhrke W Schulz M

7. Jahrestagung der Deutschen Gesellschaft für Epidemiologie (DGEpi), 26. - 29. September 2012, Regensburg.

Abstract Schuessel DGEpi 2012 Regensburg

Conflicts of interests: Eine ähnliche, Vorläufer-Studie wurde finanziell unterstützt durch Procter & Gamble Pharmaceuticals-Germany GmbH, jetzt Warner Chilcott Deutschland GmbH. WM war Angestellter bei Procter & Gamble Pharmaceuticals-Germany GmbH / Warner Chilcott Deutschland GmbH. A similar, preceding study was financially supported by Procter & Gamble Pharmaceuticals-Germany GmbH, now Warner Chilcott Deutschland GmbH. WM was employee of Procter & Gamble Pharmaceuticals-Germany GmbH / Warner Chilcott Deutschland GmbH.

Evaluation of pharmaceutical concerns in Germany: frequency and potential reasons

Adherence to antihypertensives: feasibility of two self-report instruments to investigate medication-taking behaviour in German community pharmacies.

Anwendung pharmazeutischer Bedenken 2016 – Eine Auswertung des Deutschen Arzneiprüfungsinstitutes e. V. (DAPI)

Temporal synchrony between drug dispensings and adverse drug events? The example of statins & rhabdomyolysis and metamizole or clozapine & agranulocytosis

Oral Antibiotics in Germany and the Netherlands in Primary Care from 2012 – 2016: A Comparison

In search of a standard when analyzing medication adherence in patients with heart failure using claims data: a systematic review.

Extemporaneous formulations in Germany - relevance for everyday clinical practice.